Chile In Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Chile in-vitro diagnostic market is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types) Product (Instrument, Reagent, Other Products), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End-Users). The report offers the value (in USD million) for the above segments.

Market Snapshot

CAGR
Study Period: 2019-2027
Base Year: 2021
CAGR: 6.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Chile's in vitro diagnostics market is expected to register a CAGR of 6.2% over the forecast period (2022-2027).

The emergence of COVID-19 has led to the health crisis that the world has witnessed and had an unprecedented impact on various industries and specifically the healthcare and biotechnology industries, including the in-vitro diagnostic market. The strict lockdowns and government regulations resulted in the restriction on the movement of people that intended to slow down the spread of COVID-19 but also resulted in a disturbed supply chain, which impacted the supply of these devices to hospitals. The COVID-19 outbreak affected Chile’s in-vitro diagnostic market’s growth adversely in its preliminary phase; however, this market is expected to gain traction due to the significant urge by rapid demand for newly launched emergency use authorized in-vitro tests used for COVID-19 detection. However, this adverse impact is being compensated by the rapid demand for newly launched emergency use authorized in vitro diagnostic tests used for COVID-19 detection. Moreover, the rising vaccination rate is expected to surge the demand for other in vitro diagnostic tests as well.

The factors which are significantly driving the market are the increasing prevalence of chronic disease and the increasing use of point-of-care (POC) diagnostics. The increasing incidence of chronic diseases like cancer is driving the Chile in-vitro diagnostic market. For instance, International Agency for Research on Cancer 2021, reported that 51.6 thousand cancer cases in Chile in the year 2020, and this number is expected to increase by 85.2 thousand in the region by 2040. Thus, increasing cases of cancer are expected to drive the demand for associated in-vitro diagnostic devices, thereby contributing to the growth of the market. For another instance, in 2022 an article titled, "Diagnosis of HIV infection using mass community rapid testing in Santiago, Chile" reported that Chile has had the highest increase in new HIV infections in Latin America in the last ten years. The HIV infection prevalence rate in the region reported was 1.03% which was twice the estimate of official sources. For another instance, in 2021 Joint United Nations Programme on HIV/AIDS (UNAIDS) and the Chilean Ministry of Health estimated that 74,000 (64,000–85,000) people are living with HIV in Chile with a 0.5% (0.5–0.6) HIV prevalence among people aged 16 – 49 years. Therefore, the high prevalence of HIV cases in the region is driving the in-vitro diagnostic tests with adequate sensitivity and specificity, thereby driving the market.

The increasing use of point-of-care diagnostics is driving the market. The largest benefit of point of care testing is that it can be done rapidly and be performed by clinical personnel. Rapid test results can provide a physician and other clinical personnel with results that can quickly help determine a course of action or treatment for a patient. Some of the most widely used point of care (POC) devices, such as blood glucose measurements and pregnancy tests, indicate in-home testing by the patients. For instance, International Diabetes Federation (IDF) 2021 reported that 1.7 million people living with diabetes in the Chile region which was 41.2 % higher than in the past decade. Thus, increasing cases of diabetes are increasing the demand if in-vitro diagnostics, thereby driving the market.

Therefore, due to the above-mentioned reasons, the market is expected to show significant growth over the forecast period. However, stringent regulations may slow down the growth of the market.

Scope of the report

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. The Chile in-vitro diagnostic market is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types) Product (Instrument, Reagent, Other Products), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End-Users). The report offers the value (in USD million) for the above segments.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Immuno Diagnostics
Hematology
Other Test Types
By Product
Instrument
Reagent
Other Products
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Other Applications
By End Users
Diagnostic Laboratories
Hospitals and Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Diabetes is Expected to Hold Significant Market Share Over the Forecast Period.

Diabetes is a chronic disorder resulting from insulin deficiency and hyperglycemia and has a high risk of development of complications for the eyes, kidneys, peripheral nerves, heart, and blood vessels. Quick diagnosis and early prevention are critical for the control of the disease status. Traditional biosensors such as glucose meters and glycohemoglobin test kits are widely used in vitro for this purpose because they are the two major indicators directly involved in diabetes diagnosis and long-term management. There has been a huge demand for these tests that make it a model disease to develop new approaches to biosensors.

The high incidence of diabetes is expected to drive the market in the region. According to International Diabetes Federation (IDF), 2021 data reported that 10.8% of Chile's population is prevalent in diabetes. The same source also quoted that 1,747.1 per 1000s adults aged between (20 –79) years are living with diabetes. Hence this is expected to increase the overall demand for early diagnostics tests like in-vitro diagnostics tests which will help the market to grow in Chile.

Thus, due to the above-mentioned reasons, the diabetes segment is expected to hold a significant market share over the forecast period.

123

Competitive Landscape

The Chile in-vitro market is consolidated in nature due to the presence of fewer companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Abbott Laboratories, Becton, Dickinson and Company, BioMérieux, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, QIAGEN NV, Siemens Healthcare GmbH, Sysmex Corporation, and Thermo Fischer Scientific Inc.

Major Players

  1. Thermo Fischer Scientific Inc.

  2. QIAGEN N.V.

  3. Abbott Laboratories

  4. Siemens Healthcare GmbH

  5. F. Hoffmann-La Roche AG

Screenshot 2022-08-18 162046.png

Recent Development

  • In January 2022, the Mexican platform announced the advancement of digital diagnostics in Latin America. Healthtech Eva has enabled remote test analysis and broadens access to healthcare by users outside large urban centers.
  • In November 2021, Todos Medical, Ltd. announced it has confirmed with its PCR test kit providers that the PCR test kits utilized at its Clinical Laboratory Improvement Amendments/Community-Acquired Pneumonia (CLIA/CAP) certified lab Provista Diagnostics based in the Atlanta, GA area can detect a SARS-CoV-2 infection caused by the Omicron variant, as well as all other variants of concern, based on in silico analysis.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Hematology

      5. 5.1.5 Other Test Types

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Other Applications

    5. 5.5 By End Users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioMérieux

      4. 6.1.4 Bio-Rad Laboratories Inc.

      5. 6.1.5 F. Hoffmann-La Roche AG

      6. 6.1.6 QIAGEN NV

      7. 6.1.7 Siemens Healthcare GmbH

      8. 6.1.8 Sysmex Corporation

      9. 6.1.9 Thermo Fischer Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Chile In Vitro Diagnostics Market market is studied from 2019 - 2027.

The Chile In Vitro Diagnostics Market is growing at a CAGR of 6.2% over the next 5 years.

Thermo Fischer Scientific Inc., QIAGEN N.V., Abbott Laboratories, Siemens Healthcare GmbH, F. Hoffmann-La Roche AG are the major companies operating in Chile In Vitro Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!